Классификация хронического панкреатита:возможности ферментной терапии

1. Коротько Г.Ф. Саморегуляция панкреатической секреции. Рос. журн. гастроэнтерол., гепатол. 1994; 3: 10–5.
2. Маев И.В., Самсонов А.А. Панзинорм форте-Н – эффективное средство для адекватной терапии синдрома мальдигестии/мальабсорбции. Cons. Med. 2005; 7 (1): 16–21.
3. Саблин О.А., Бутенко Е.В. Ферментные препараты в гастроэнтерологии. Cons. Med. 2004; Прил. 1: 11–7.
4. Шифрин О.С., Юрьева Е.Ю., Ивашкин В.Т. Клиническое применение пензитала при хроническом панкреатите. Клин. перспект. гастроэнтерол., гепатол. 2004; 1: 32–4.
5. Bu..chler M., Martignoni M., Friess H., Malfertheiner P. A proposal for a new clinical classification of chronic pancreatitis. BMC Gastroenterol 2009; 9: 93–101.
6. Czakу L, Takocs T, Hegyi P et al. Quality of life assessment after pancreatic enzyme replacement therapy in chronic pancreatitis. Can J Gastroenterol 2003; 17: 597–603.
7. Dominguez-Munoz JВ, Iglesias-Garcia J. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy? JOP 2010; 2: 158–62.
8. Dominguez-Munoz JВ. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep 2007; 9: 116–22.
9. Etemad B, Whitcomb D. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 3: 682–707.
10. Finkelberg D, Sahani D, Deshpande V, Brugge W. Autoimmune pancreatitis. N Engl J Med 2006; 355: 2670–6.
11. Jaster R. Molecular regulation of pancreatic stellate cell function. Mol Cancer 2004; 3: 26.
12. Kim K, Kim M, Lee Y et al. Clinical characteristics of 17 cases of autoimmune chronic pancreatitis. Korean J Gastroenterol 2004; 43: 112–9.
13. Knop F, Vilsboll T, Larsen S et al. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. Am J Physiol Endocrinol Metab 2007; 292: E324-E330.
14. Mizushima T, Ochi K, Ichimura M et al. Pancreatic enzyme supplement improves dysmotility in chronic pancreatitis patients. J Gastroenterol Hepatol 2004; 19: 1005–9.
15. Nahon Uzan K, Levy P, O'Toole D et al. Is idiopathic chronic pancreatitis an autoimmune disease? Clin Gastroenterol Hepatol 2005; 3: 903–9.
16. O'Keefe S, Cariem A, Levy M. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J Clin Gastroenterol 2001; 32: 319–23.
17. Pearson R, Longnecker D, Chari S et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 2003; 27: 1–13.
18. Safdi M, Bekal P, Martin S et al. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebocontrolled, parallel group trial in subjects with chronic pancreatitis. Pancreas 2006; 33: 156–62.
19. Schneider A, Lohr J, Singer M. The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol 2007; 42: 101–19.
20. Trolli P, Conwell D, Zuccaro G. Pancreatic enzyme therapy and nutritional status of outpatients with chronic pancreatitis. Gastroenterol Nurs 2001; 24: 84–7.
21. Vuoristo M, Vaananen H, Miettinen T. Cholesterol malabsorption in pancreatic insufficiency: effects of enzyme substitution. Gastroenterology 1994; 102: 647–55.